Biblio
Export 1530 results:
Author [ Title
Filters: First Letter Of Last Name is K [Clear All Filters]
“The Complexity of Nutritional Problems in Persons with Dementia: Expanding a Theoretical Model.”, J Alzheimers Dis, vol. 96, no. 1, pp. 183-192, 2023.
, “The Complexity of Nutritional Problems in Persons with Dementia: Expanding a Theoretical Model.”, J Alzheimers Dis, vol. 96, no. 1, pp. 183-192, 2023.
, “A Comparison of Partial Volume Correction Techniques for Measuring Change in Serial Amyloid PET SUVR.”, J Alzheimers Dis, vol. 67, no. 1, pp. 181-195, 2019.
, “Comparison of Gait Parameters for Predicting Cognitive Decline: The Mayo Clinic Study of Aging.”, J Alzheimers Dis, vol. 55, no. 2, pp. 559-567, 2017.
, “Comparison of Different Matrices as Potential Quality Control Samples for Neurochemical Dementia Diagnostics.”, J Alzheimers Dis, vol. 52, no. 1, pp. 51-64, 2016.
, “Comparison of Different Matrices as Potential Quality Control Samples for Neurochemical Dementia Diagnostics.”, J Alzheimers Dis, vol. 52, no. 1, pp. 51-64, 2016.
, “Comparison of Different Matrices as Potential Quality Control Samples for Neurochemical Dementia Diagnostics.”, J Alzheimers Dis, vol. 52, no. 1, pp. 51-64, 2016.
, “Comparison of Different Hypotheses Regarding the Spread of Alzheimer's Disease Using Markov Random Fields and Multimodal Imaging.”, J Alzheimers Dis, vol. 65, no. 3, pp. 731-746, 2018.
, “Comparative Efficacy, Tolerability, and Acceptability of Donanemab, Lecanemab, Aducanumab, Melatonin, and Aerobic Exercise for a Short Time on Cognitive Function in Mild Cognitive Impairment and Mild Alzheimer's Disease”, J Alzheimers Dis, vol. 98, no. 3, pp. 825-835, 2024.
, “Comorbidity Analysis between Alzheimer's Disease and Type 2 Diabetes Mellitus (T2DM) Based on Shared Pathways and the Role of T2DM Drugs.”, J Alzheimers Dis, vol. 60, no. 2, pp. 721-731, 2017.
, “Comorbidity Analysis between Alzheimer's Disease and Type 2 Diabetes Mellitus (T2DM) Based on Shared Pathways and the Role of T2DM Drugs.”, J Alzheimers Dis, vol. 60, no. 2, pp. 721-731, 2017.
, “A Common Variant of IL-6R is Associated with Elevated IL-6 Pathway Activity in Alzheimer's Disease Brains.”, J Alzheimers Dis, vol. 56, no. 3, pp. 1037-1054, 2017.
, “A Common Variant of IL-6R is Associated with Elevated IL-6 Pathway Activity in Alzheimer's Disease Brains.”, J Alzheimers Dis, vol. 56, no. 3, pp. 1037-1054, 2017.
, “The Coming of Age of the Angiotensin Hypothesis in Alzheimer's Disease: Progress Toward Disease Prevention and Treatment?”, J Alzheimers Dis, vol. 62, no. 3, pp. 1443-1466, 2018.
, “Combining Multimodal Behavioral Data of Gait, Speech, and Drawing for Classification of Alzheimer's Disease and Mild Cognitive Impairment.”, J Alzheimers Dis, vol. 84, no. 1, pp. 315-327, 2021.
, “Combining Cognitive, Genetic, and Structural Neuroimaging Markers to Identify Individuals with Increased Dementia Risk.”, J Alzheimers Dis, vol. 64, no. 2, pp. 533-542, 2018.
, “Combining Cognitive, Genetic, and Structural Neuroimaging Markers to Identify Individuals with Increased Dementia Risk.”, J Alzheimers Dis, vol. 64, no. 2, pp. 533-542, 2018.
, “Combination Therapy with Zonisamide and Antiparkinson Drugs for Parkinson's Disease: A Meta-Analysis.”, J Alzheimers Dis, vol. 56, no. 4, pp. 1229-1239, 2017.
, “Combination Therapy of Serotonin Reuptake Inhibitors and Memantine for Obsessive- Compulsive Disorder: A Meta-Analysis of Double-Blind, Randomized, Placebo-Controlled Trials.”, J Alzheimers Dis, vol. 64, no. 1, pp. 43-48, 2018.
, “Co-Localization of Glia Maturation Factor with NLRP3 Inflammasome and Autophagosome Markers in Human Alzheimer's Disease Brain.”, J Alzheimers Dis, vol. 60, no. 3, pp. 1143-1160, 2017.
, “Colocalization of Aluminum and Iron in Nuclei of Nerve Cells in Brains of Patients with Alzheimer's Disease.”, J Alzheimers Dis, vol. 65, no. 4, pp. 1267-1281, 2018.
, “Collapsin Response Mediator Protein-2 (CRMP2) is a Plausible Etiological Factor and Potential Therapeutic Target in Alzheimer's Disease: Comparison and Contrast with Microtubule-Associated Protein Tau.”, J Alzheimers Dis, vol. 53, no. 1, pp. 1-14, 2016.
, “Cohort Effects in the Prevalence and Survival of People with Dementia in a Rural Area in Northern Sweden.”, J Alzheimers Dis, vol. 50, no. 2, pp. 387-96, 2016.
, “Cognitive Variability Predicts Incident Alzheimer's Disease and Mild Cognitive Impairment Comparable to a Cerebrospinal Fluid Biomarker.”, J Alzheimers Dis, vol. 61, no. 1, pp. 79-89, 2018.
, “Cognitive Training Interventions for Patients with Alzheimer's Disease: A Systematic Review.”, J Alzheimers Dis, vol. 56, no. 4, pp. 1349-1372, 2017.
,